Thu, Jul 04, 2024
Zydus Lifesciences Share Price Target: Anil Singhvi has advised investors to buy this pharma stock when it is available in the range of Rs 1,100.
More >
Lupin shares saw significant rise on Thursday after brokerage double uprgraded it to 'add'. It has given 12-month target of Rs 1,805 for the stock.
Wed, Dec 06, 2023
Aclaris Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel drugs for immuno-inflammatory diseases.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.